Don't Sell Oncolytics - Hold or Buy ItRetail investors hold onto your shares the April 2009 story of Dendreon, DNDN on the Nasdaq, is going to be repeated with Oncolytics soon. Consider buying and using margin. Institutional investors are wise to recognize the risk of condoning the buy side manipulation and acquire their position quickly.
Here is table showing the trading of Dendreon in April 2009.
Date | Closing Price | Volume |
1-Apr-09 | $4.14 | 3,199,650 |
2-Apr-09 | 4.34 | 2,427,867 |
3-Apr-09 | 5.99 | 22,497,200 |
6-Apr-09 | 6.58 | 19,585,750 |
7-Apr-09 | 6.58 | 7,346,062 |
8-Apr-09 | 6.37 | 5,392,639 |
9-Apr-09 | 6.30 | 4,234,697 |
13-Apr-09 | 7.30 | 12,775,310 |
14-Apr-09 | 16.99 | 65,120,890 |
15-Apr-09 | 17.17 | 19,294,060 |
16-Apr-09 | 17.03 | 6,894,881 |
17-Apr-09 | 17.99 | 17,799,470 |
20-Apr-09 | 19.52 | 17,724,250 |
21-Apr-09 | 19.74 | 11,008,510 |
22-Apr-09 | 20.12 | 7,358,435 |
23-Apr-09 | 20.33 | 6,123,418 |
24-Apr-09 | 20.08 | 7,393,327 |
27-Apr-09 | 21.55 | 18,569,850 |
28-Apr-09 | 11.81 | 28,070,740 |
29-Apr-09 | 22.94 | 48,235,790 |
30-Apr-09 | 21.20 | 17,468,950 |
Yesterday | | |
8-Mar-11 | $32.46 | 2,036,250 |